European regulators have approved Boston Scientific Corp’s plans to market a system that remotely monitors patients that have been implanted with cardiac defibrillators. Boston Scientific’s patient management system, dubbed Latitude, incorporates a blood pressure monitor and collects data on the performance of person’s heart and that of the defibrillator itself. Latitude reports information it collects back to doctors.